| Bioactivity | PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III), a multikinase inhibitor, inhibits PDGFR, EGFR, FGFR, PKA, and PKC, respectively. PDGFR Tyrosine Kinase Inhibitor III can be used for the research of amyotrophic lateral sclerosis[1]. | ||||||||||||
| Name | PDGFR Tyrosine Kinase Inhibitor III | ||||||||||||
| CAS | 205254-94-0 | ||||||||||||
| Formula | C27H27N5O4 | ||||||||||||
| Molar Mass | 485.53 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Young-Min Lee. Compositions and methods for zika virus characterization and vaccine development. WO2019204654A1. |
PDGFR Tyrosine Kinase Inhibitor III
CAS: 205254-94-0 F: C27H27N5O4 W: 485.53
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III), a multikinase inhibitor, inhibits PDG
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.